Product Details
Source
Monoclonal Anti-Human CD3 Antibody, Mouse IgG2a (Clone: OKT3) is a monoclonal antibody recombinantly expressed from human 293 cells (HEK293), which provides higher batch consistency and long term security of supply.
Antibody Type
Recombinant Monoclonal
Clone
OKT3
Isotype
Mouse IgG2a, Kappa
Host Species
Mouse
Reactivity
Human
Immunogen
Purified Human CD3ε Protein
Conjugate
FITC
Excitation source: 488 nm spectral line, argon-ion laser
Excitation Wavelength: 488 nm
Emission Wavelength: 535 nm
Specificity
This product is a specific antibody specifically reacts with CD3 protein.
Application
This FITC-CD3 Antibody is specifically developed for flow cytometry applications to detect the expression of CD3 on human cells. Additionally, the Human TBNK 6-color Cocktail Flow Panel kit (Cat. No. ICA-A001) is available, with the FITC-CD3 Antibody being one component of the kit.
Recommended Dilution
1:20
Isotype Control
The isotype control is sold separately; please refer to Cat. No. DNP-FM487 for product information.
Form
Liquid
Formulation
Supplied as 0.2 μm-filtered solution in PBS (pH 7.4), with trehalose as protectant.
Please contact us for customized product forms or formulations.
Shipping
Liquid product is shipped at blue ice.
Storage
Please protect from light and avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- Store at 2-8 °C for 12 months.
Notices
Product Specific Notices: For research use only.
ACRO Quality Management System
Customers Also Viewed
Performance Data
Bioactivity-FACS

Flow cytometric analysis of Human peripheral blood lymphocytes respectively staining with FITC-Labeled Monoclonal Anti-Human CD3 Antibody Mouse IgG2a (Cat. No. FABm001-03) at 1:20 dilution (5 μL of the antibody stock solution corresponds to labeling of 2.5e5 cells in a final volume of 100 µL), compared with isotype control antibody. FITC signal was used to evaluate the binding activity (QC tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
T cell surface glycoprotein CD3
- Category:
- Approved Drugs:
10 Details
- Drugs in Clinical Trials:
198 Details
- Highest Development Stage:
Approved
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521



















